Stratagene in Settlement Talks with Applera, Third Wave; Calls Bayer Pact 'Sound' Despite Siemens Buy | GenomeWeb

Stratagene is involved in settlement discussions with Applera and Third Wave Technologies in two separate cases, according to court documents filed over the past month.

Resolving the disputes could decrease Stratagene's legal expenses and erase concerns among potential partners that the firm's products may infringe other technologies. It could also provide a boost to Stratagene's sagging stock, which has hovered around its 52-week low for most of the past month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.